499 related articles for article (PubMed ID: 23958548)
1. Diagnostic utility of PLAG1 immunohistochemical determination in salivary gland tumors.
Rotellini M; Palomba A; Baroni G; Franchi A
Appl Immunohistochem Mol Morphol; 2014; 22(5):390-4. PubMed ID: 23958548
[TBL] [Abstract][Full Text] [Related]
2. PLAG1 immunohistochemistry is a sensitive marker for pleomorphic adenoma: a comparative study with PLAG1 genetic abnormalities.
Katabi N; Xu B; Jungbluth AA; Zhang L; Shao SY; Lane J; Ghossein R; Antonescu CR
Histopathology; 2018 Jan; 72(2):285-293. PubMed ID: 28796899
[TBL] [Abstract][Full Text] [Related]
3. PLAG1: An Immunohistochemical Marker with Limited Utility in Separating Pleomorphic Adenoma from Other Basaloid Salivary Gland Tumors.
Avadhani V; Cohen C; Siddiqui MT
Acta Cytol; 2016; 60(3):240-5. PubMed ID: 27463119
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of translocation-associated immunohistochemical stains in the fine-needle aspiration diagnosis of salivary gland neoplasms.
Foo WC; Jo VY; Krane JF
Cancer Cytopathol; 2016 Jun; 124(6):397-405. PubMed ID: 26882287
[TBL] [Abstract][Full Text] [Related]
5. Glial Fibrillary Acidic Protein Expression Helps Distinguish Pleomorphic Adenoma from Histologic Mimics.
Gorski Z; Purgina B; Wasserman JK
Head Neck Pathol; 2022 Sep; 16(3):695-702. PubMed ID: 35064902
[TBL] [Abstract][Full Text] [Related]
6. Subsets of salivary duct carcinoma defined by morphologic evidence of pleomorphic adenoma, PLAG1 or HMGA2 rearrangements, and common genetic alterations.
Chiosea SI; Thompson LD; Weinreb I; Bauman JE; Mahaffey AM; Miller C; Ferris RL; Gooding WE
Cancer; 2016 Oct; 122(20):3136-3144. PubMed ID: 27379604
[TBL] [Abstract][Full Text] [Related]
7. NR4A3 Immunohistochemistry Reliably Discriminates Acinic Cell Carcinoma from Mimics.
Wong KS; Mariño-Enriquez A; Hornick JL; Jo VY
Head Neck Pathol; 2021 Jun; 15(2):425-432. PubMed ID: 32910350
[TBL] [Abstract][Full Text] [Related]
8. Loss of expression of Plag1 in malignant transformation from pleomorphic adenoma to carcinoma ex pleomorphic adenoma.
de Brito BS; Giovanelli N; Egal ES; Sánchez-Romero C; Nascimento JS; Martins AS; Tincani ÁJ; Del Negro A; Gondak RO; Almeida OP; Kowalski LP; Altemani A; Mariano FV
Hum Pathol; 2016 Nov; 57():152-159. PubMed ID: 27473265
[TBL] [Abstract][Full Text] [Related]
9. Homeobox transcription factor engrailed homeobox 1 is a possible diagnostic marker for adenoid cystic carcinoma and polymorphous adenocarcinoma.
Baba S; Akashi T; Kayamori K; Ohuchi T; Ogawa I; Kubota N; Nakano K; Nagatsuka H; Hasegawa H; Matsuzaka K; Tomii S; Uchida K; Katsuta N; Sekiya T; Ando N; Miura K; Ishibashi H; Ariizumi Y; Asakage T; Michi Y; Harada H; Sakamoto K; Eishi Y; Okubo K; Ikeda T
Pathol Int; 2021 Feb; 71(2):113-123. PubMed ID: 33333616
[TBL] [Abstract][Full Text] [Related]
10. Consistent PLAG1 and HMGA2 abnormalities distinguish carcinoma ex-pleomorphic adenoma from its de novo counterparts.
Katabi N; Ghossein R; Ho A; Dogan S; Zhang L; Sung YS; Antonescu CR
Hum Pathol; 2015 Jan; 46(1):26-33. PubMed ID: 25439740
[TBL] [Abstract][Full Text] [Related]
11. Recurrent rearrangements of the PLAG1 and HMGA2 genes in lacrimal gland pleomorphic adenoma and carcinoma ex pleomorphic adenoma.
Andreasen S; von Holstein SL; Homøe P; Heegaard S
Acta Ophthalmol; 2018 Nov; 96(7):e768-e771. PubMed ID: 29437290
[TBL] [Abstract][Full Text] [Related]
12. PLAG1 expression is maintained in recurrent pleomorphic adenoma.
de Brito BS; Gaspar NG; Egal ES; Sanchez-Romero C; Martins AS; Tincani ÁJ; de Oliveira Gondak R; de Almeida OP; Kowalski LP; Altemani A; Mariano FV
Virchows Arch; 2016 Oct; 469(4):477-81. PubMed ID: 27381214
[TBL] [Abstract][Full Text] [Related]
13. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas.
Edwards PC; Bhuiya T; Kelsch RD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 May; 97(5):613-9. PubMed ID: 15153875
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic value of MYB protein expression in adenoid cystic carcinoma and status of MYB gene copy number].
Huo Z; Zeng X; Wu S; Wu H; Meng Y; Liu Y; Luo Y; Cao J; Liang Z
Zhonghua Bing Li Xue Za Zhi; 2015 Aug; 44(8):582-6. PubMed ID: 26705183
[TBL] [Abstract][Full Text] [Related]
15. Lacrimal gland pleomorphic adenoma and carcinoma ex pleomorphic adenoma: genomic profiles, gene fusions, and clinical characteristics.
von Holstein SL; Fehr A; Persson M; Nickelsen M; Therkildsen MH; Prause JU; Heegaard S; Stenman G
Ophthalmology; 2014 May; 121(5):1125-33. PubMed ID: 24468654
[TBL] [Abstract][Full Text] [Related]
16. HMGA2 is a specific immunohistochemical marker for pleomorphic adenoma and carcinoma ex-pleomorphic adenoma.
Mito JK; Jo VY; Chiosea SI; Dal Cin P; Krane JF
Histopathology; 2017 Oct; 71(4):511-521. PubMed ID: 28463429
[TBL] [Abstract][Full Text] [Related]
17. Pediatric epithelial salivary gland tumors: spectrum of histologies and cytogenetics at a children's hospital.
Craver RD; Fonseca P; Carr R
Pediatr Dev Pathol; 2010; 13(5):348-53. PubMed ID: 20055685
[TBL] [Abstract][Full Text] [Related]
18. SOX10-positive salivary gland tumors: a growing list, including mammary analogue secretory carcinoma of the salivary gland, sialoblastoma, low-grade salivary duct carcinoma, basal cell adenoma/adenocarcinoma, and a subgroup of mucoepidermoid carcinoma.
Hsieh MS; Lee YH; Chang YL
Hum Pathol; 2016 Oct; 56():134-42. PubMed ID: 27327192
[TBL] [Abstract][Full Text] [Related]
19. Don't SUMP it! Utility of PLAG1 immunocytochemistry in basaloid SUMP subcategory.
Sanchez-Avila M; Tjendra Y; Zuo Y; Ruiz-Cordero R; Garcia-Buitrago M; Jorda M; Gomez-Fernandez C; Velez Torres JM
Cancer Cytopathol; 2024 Jan; 132(1):60-68. PubMed ID: 37702124
[TBL] [Abstract][Full Text] [Related]
20. The morphological spectrum of salivary gland type tumours of the breast.
Foschini MP; Morandi L; Asioli S; Giove G; Corradini AG; Eusebi V
Pathology; 2017 Feb; 49(2):215-227. PubMed ID: 28043647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
